If you are not a current client of Bereskin & Parr LLP, please do not include any information in this email that you or someone else considers confidential. You do not become a client of the firm until the firm agrees to act for you and confirms representation in writing. Until that time what you send us cannot be protected from disclosure.
Herman Cheung is an associate with Bereskin & Parr LLP and is a member of the Life Sciences practice group. His practice includes all aspects of patent prosecution for Canadian, European and United States applications.
He completed his Ph.D. on the neurochemistry of stroke and heart attack at the University of Toronto and was a postdoctoral fellow at the Apoptosis Research Centre in Ottawa, where he undertook research relating to cancer treatment. Herman is the recipient of the Ontario Graduate Scholarship in Science and Technology and the Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship.
Herman has co-authored articles published in Nature Biotechnology, Nature Immunology, Cell Death and Differentiation, Journal of Neurochemistry, Journal of Biological Chemistry, PNAS, Clinical Cancer Research, Cancer Research, Trends in Immunology, and Current Opinion in Investigational Drugs.
Herman was an articling and summer student with Bereskin & Parr. He also worked as a biochemist at the Ontario Institute for Cancer Research in Toronto before attending law school at the University of Toronto.